Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Fetofetal Transfusion | 34 | 2025 | 192 | 9.460 |
Why?
|
Ultrasonography, Prenatal | 55 | 2025 | 963 | 6.270 |
Why?
|
Fetoscopy | 50 | 2025 | 439 | 6.170 |
Why?
|
Fetal Diseases | 24 | 2024 | 447 | 5.880 |
Why?
|
Pregnancy | 143 | 2025 | 7167 | 4.970 |
Why?
|
Pregnancy, Twin | 29 | 2025 | 177 | 4.120 |
Why?
|
Urethral Obstruction | 7 | 2024 | 56 | 3.590 |
Why?
|
Meningomyelocele | 17 | 2025 | 237 | 3.080 |
Why?
|
Premature Birth | 14 | 2023 | 384 | 2.980 |
Why?
|
Neural Tube Defects | 16 | 2024 | 351 | 2.680 |
Why?
|
Fetal Membranes, Premature Rupture | 7 | 2023 | 60 | 2.570 |
Why?
|
Laser Coagulation | 10 | 2024 | 129 | 2.520 |
Why?
|
Fetal Growth Retardation | 10 | 2025 | 240 | 2.480 |
Why?
|
Gestational Age | 38 | 2025 | 1161 | 2.430 |
Why?
|
Laser Therapy | 12 | 2023 | 250 | 2.410 |
Why?
|
Pregnancy Outcome | 28 | 2025 | 589 | 2.360 |
Why?
|
Infant, Newborn | 59 | 2025 | 8180 | 2.080 |
Why?
|
Oligohydramnios | 4 | 2025 | 46 | 1.960 |
Why?
|
Female | 145 | 2025 | 66235 | 1.940 |
Why?
|
Polycythemia | 4 | 2024 | 43 | 1.870 |
Why?
|
Delivery, Obstetric | 4 | 2022 | 250 | 1.820 |
Why?
|
Placenta | 15 | 2023 | 506 | 1.740 |
Why?
|
Fetus | 20 | 2023 | 584 | 1.700 |
Why?
|
Perinatal Death | 2 | 2023 | 26 | 1.690 |
Why?
|
Retrospective Studies | 80 | 2025 | 16226 | 1.650 |
Why?
|
Prenatal Diagnosis | 15 | 2025 | 597 | 1.580 |
Why?
|
Amniotic Fluid | 6 | 2025 | 151 | 1.560 |
Why?
|
Hysterotomy | 14 | 2025 | 126 | 1.530 |
Why?
|
Fetal Therapies | 8 | 2020 | 72 | 1.530 |
Why?
|
Placenta Accreta | 10 | 2024 | 155 | 1.500 |
Why?
|
Humans | 147 | 2025 | 124299 | 1.360 |
Why?
|
Amniotic Band Syndrome | 2 | 2020 | 24 | 1.360 |
Why?
|
Urologic Diseases | 3 | 2021 | 45 | 1.350 |
Why?
|
Twins, Monozygotic | 12 | 2025 | 117 | 1.330 |
Why?
|
Cesarean Section | 16 | 2021 | 387 | 1.300 |
Why?
|
Hydrocephalus | 6 | 2024 | 245 | 1.300 |
Why?
|
Anemia | 3 | 2022 | 339 | 1.280 |
Why?
|
Hydrops Fetalis | 4 | 2022 | 75 | 1.270 |
Why?
|
Adult | 64 | 2025 | 29386 | 1.170 |
Why?
|
Labor, Obstetric | 3 | 2022 | 94 | 1.100 |
Why?
|
Fetal Heart | 3 | 2017 | 117 | 1.090 |
Why?
|
Prenatal Care | 9 | 2023 | 348 | 1.080 |
Why?
|
Abruptio Placentae | 2 | 2023 | 17 | 1.070 |
Why?
|
Umbilical Arteries | 6 | 2021 | 94 | 1.060 |
Why?
|
Spina Bifida Cystica | 3 | 2024 | 35 | 1.050 |
Why?
|
Labor Presentation | 2 | 2022 | 10 | 0.960 |
Why?
|
Polyhydramnios | 4 | 2025 | 56 | 0.960 |
Why?
|
Pregnancy Complications | 6 | 2022 | 507 | 0.920 |
Why?
|
Lasers | 9 | 2024 | 115 | 0.920 |
Why?
|
Teratoma | 3 | 2024 | 123 | 0.900 |
Why?
|
Sutures | 1 | 2024 | 67 | 0.870 |
Why?
|
Pleural Effusion | 3 | 2024 | 101 | 0.870 |
Why?
|
Indomethacin | 2 | 2021 | 84 | 0.870 |
Why?
|
Hernias, Diaphragmatic, Congenital | 6 | 2025 | 402 | 0.850 |
Why?
|
Urinary Tract | 1 | 2023 | 60 | 0.850 |
Why?
|
Surgical Wound Dehiscence | 2 | 2020 | 51 | 0.840 |
Why?
|
Gastroschisis | 2 | 2020 | 53 | 0.840 |
Why?
|
Chorioamnionitis | 1 | 2022 | 42 | 0.800 |
Why?
|
Neurosurgical Procedures | 4 | 2021 | 307 | 0.780 |
Why?
|
Labor Stage, Second | 1 | 2021 | 16 | 0.750 |
Why?
|
Cohort Studies | 19 | 2024 | 4731 | 0.740 |
Why?
|
Hydronephrosis | 1 | 2021 | 35 | 0.730 |
Why?
|
Ascites | 1 | 2021 | 88 | 0.720 |
Why?
|
Postoperative Complications | 7 | 2021 | 3067 | 0.710 |
Why?
|
Extraembryonic Membranes | 1 | 2020 | 14 | 0.710 |
Why?
|
Uterine Rupture | 1 | 2020 | 18 | 0.700 |
Why?
|
Myometrium | 1 | 2020 | 47 | 0.690 |
Why?
|
Hysterectomy | 7 | 2021 | 192 | 0.680 |
Why?
|
Polytetrafluoroethylene | 1 | 2020 | 83 | 0.680 |
Why?
|
Cyclooxygenase Inhibitors | 1 | 2020 | 63 | 0.670 |
Why?
|
Pregnancy Trimester, Second | 7 | 2024 | 166 | 0.660 |
Why?
|
Spinal Dysraphism | 5 | 2023 | 267 | 0.660 |
Why?
|
Kidney | 4 | 2021 | 1345 | 0.660 |
Why?
|
Ductus Arteriosus | 1 | 2020 | 63 | 0.650 |
Why?
|
Light Coagulation | 5 | 2023 | 24 | 0.640 |
Why?
|
Cicatrix | 1 | 2020 | 123 | 0.640 |
Why?
|
Constriction, Pathologic | 1 | 2020 | 244 | 0.630 |
Why?
|
Airway Obstruction | 4 | 2023 | 165 | 0.630 |
Why?
|
Salpingostomy | 1 | 2018 | 1 | 0.630 |
Why?
|
Ovarian Hyperstimulation Syndrome | 1 | 2018 | 9 | 0.630 |
Why?
|
Pregnancy, Tubal | 1 | 2018 | 4 | 0.620 |
Why?
|
Subcutaneous Fat, Abdominal | 1 | 2018 | 2 | 0.620 |
Why?
|
Meningocele | 1 | 2018 | 19 | 0.610 |
Why?
|
Organ Sparing Treatments | 1 | 2018 | 35 | 0.600 |
Why?
|
Pulsatile Flow | 5 | 2021 | 126 | 0.590 |
Why?
|
Fallopian Tubes | 1 | 2018 | 71 | 0.590 |
Why?
|
Anthropometry | 1 | 2018 | 197 | 0.570 |
Why?
|
Ventriculoperitoneal Shunt | 2 | 2019 | 49 | 0.570 |
Why?
|
Hypertension, Pregnancy-Induced | 1 | 2018 | 74 | 0.560 |
Why?
|
Placental Circulation | 2 | 2020 | 23 | 0.560 |
Why?
|
Blood Transfusion, Intrauterine | 3 | 2024 | 37 | 0.550 |
Why?
|
Magnetic Resonance Imaging | 11 | 2025 | 3578 | 0.550 |
Why?
|
Edema | 2 | 2022 | 136 | 0.550 |
Why?
|
Pericardium | 1 | 2017 | 82 | 0.540 |
Why?
|
Kidney Diseases | 1 | 2021 | 477 | 0.540 |
Why?
|
Sepsis | 1 | 2021 | 479 | 0.530 |
Why?
|
Diabetes, Gestational | 1 | 2018 | 112 | 0.530 |
Why?
|
Heart Neoplasms | 1 | 2017 | 102 | 0.530 |
Why?
|
Placenta Previa | 4 | 2021 | 65 | 0.520 |
Why?
|
Arm | 1 | 2016 | 80 | 0.520 |
Why?
|
Pregnancy in Diabetics | 1 | 2016 | 20 | 0.520 |
Why?
|
Ovary | 1 | 2018 | 380 | 0.510 |
Why?
|
Diseases in Twins | 3 | 2021 | 94 | 0.500 |
Why?
|
Placenta Diseases | 3 | 2022 | 59 | 0.490 |
Why?
|
Treatment Outcome | 22 | 2025 | 12288 | 0.490 |
Why?
|
Perinatal Mortality | 3 | 2020 | 43 | 0.480 |
Why?
|
Young Adult | 20 | 2023 | 8976 | 0.460 |
Why?
|
Body Mass Index | 1 | 2020 | 1547 | 0.440 |
Why?
|
Fetal Death | 3 | 2023 | 112 | 0.430 |
Why?
|
Pregnancy Complications, Infectious | 4 | 2024 | 449 | 0.420 |
Why?
|
Cerebrovascular Circulation | 1 | 2016 | 433 | 0.410 |
Why?
|
Watchful Waiting | 2 | 2023 | 68 | 0.410 |
Why?
|
Urinary Bladder | 3 | 2024 | 244 | 0.410 |
Why?
|
Blood Loss, Surgical | 5 | 2019 | 152 | 0.400 |
Why?
|
Pregnancy, Triplet | 2 | 2022 | 10 | 0.400 |
Why?
|
Ultrasonography | 3 | 2022 | 927 | 0.390 |
Why?
|
Infant | 14 | 2025 | 12471 | 0.380 |
Why?
|
Ultrasonography, Doppler | 5 | 2020 | 193 | 0.370 |
Why?
|
Perinatal Care | 3 | 2022 | 67 | 0.340 |
Why?
|
Hemangioma | 2 | 2022 | 94 | 0.330 |
Why?
|
Pregnancy Reduction, Multifetal | 4 | 2022 | 20 | 0.330 |
Why?
|
Obstetric Labor, Premature | 2 | 2020 | 85 | 0.330 |
Why?
|
Walking | 2 | 2024 | 212 | 0.330 |
Why?
|
Magnesium Sulfate | 2 | 2021 | 50 | 0.320 |
Why?
|
Risk Factors | 13 | 2023 | 10138 | 0.320 |
Why?
|
Motor Activity | 3 | 2021 | 522 | 0.320 |
Why?
|
Prospective Studies | 7 | 2023 | 6075 | 0.310 |
Why?
|
Laparotomy | 3 | 2024 | 135 | 0.300 |
Why?
|
Odds Ratio | 3 | 2021 | 1245 | 0.300 |
Why?
|
Fetal Weight | 4 | 2023 | 61 | 0.300 |
Why?
|
Birth Weight | 5 | 2022 | 348 | 0.290 |
Why?
|
Neurodevelopmental Disorders | 2 | 2025 | 506 | 0.290 |
Why?
|
Heart Defects, Congenital | 2 | 2017 | 1817 | 0.290 |
Why?
|
Carbon Dioxide | 4 | 2023 | 273 | 0.280 |
Why?
|
Trachea | 4 | 2023 | 201 | 0.270 |
Why?
|
Incidence | 4 | 2021 | 3079 | 0.270 |
Why?
|
Education, Graduate | 3 | 2021 | 20 | 0.270 |
Why?
|
Delphi Technique | 2 | 2024 | 210 | 0.260 |
Why?
|
Amniocentesis | 2 | 2023 | 78 | 0.250 |
Why?
|
Lung | 5 | 2025 | 1483 | 0.250 |
Why?
|
Blood Component Transfusion | 3 | 2021 | 53 | 0.250 |
Why?
|
ROC Curve | 3 | 2022 | 561 | 0.240 |
Why?
|
Case-Control Studies | 7 | 2025 | 3268 | 0.240 |
Why?
|
Congenital Abnormalities | 2 | 2018 | 254 | 0.240 |
Why?
|
Echocardiography | 3 | 2021 | 1052 | 0.230 |
Why?
|
Sacrococcygeal Region | 1 | 2024 | 32 | 0.230 |
Why?
|
Diagnosis, Differential | 2 | 2021 | 1891 | 0.230 |
Why?
|
Tensile Strength | 1 | 2024 | 39 | 0.230 |
Why?
|
Polyesters | 1 | 2024 | 40 | 0.230 |
Why?
|
Materials Testing | 1 | 2024 | 73 | 0.230 |
Why?
|
Cerebral Ventricles | 1 | 2024 | 82 | 0.220 |
Why?
|
Iatrogenic Disease | 2 | 2022 | 132 | 0.220 |
Why?
|
Texas | 7 | 2021 | 3580 | 0.220 |
Why?
|
Predictive Value of Tests | 5 | 2021 | 2122 | 0.220 |
Why?
|
Pregnancy Trimester, First | 1 | 2024 | 114 | 0.220 |
Why?
|
Postpartum Hemorrhage | 3 | 2019 | 96 | 0.210 |
Why?
|
Stillbirth | 1 | 2023 | 80 | 0.210 |
Why?
|
Balloon Occlusion | 1 | 2022 | 47 | 0.200 |
Why?
|
Depression, Postpartum | 1 | 2023 | 53 | 0.200 |
Why?
|
Amnion | 2 | 2020 | 38 | 0.200 |
Why?
|
Aftercare | 2 | 2021 | 147 | 0.200 |
Why?
|
Child Development | 1 | 2025 | 265 | 0.200 |
Why?
|
Pregnancy Complications, Neoplastic | 1 | 2022 | 61 | 0.200 |
Why?
|
Tocolytic Agents | 1 | 2021 | 12 | 0.190 |
Why?
|
Goiter | 1 | 2021 | 7 | 0.190 |
Why?
|
Hyperthyroidism | 1 | 2021 | 26 | 0.190 |
Why?
|
Respiratory System Abnormalities | 1 | 2022 | 42 | 0.190 |
Why?
|
Medical Overuse | 1 | 2021 | 25 | 0.190 |
Why?
|
Perineum | 1 | 2021 | 48 | 0.190 |
Why?
|
Consensus | 1 | 2024 | 628 | 0.180 |
Why?
|
Nephrology | 1 | 2023 | 145 | 0.180 |
Why?
|
Rhombencephalon | 1 | 2021 | 46 | 0.180 |
Why?
|
Abortion, Spontaneous | 1 | 2022 | 79 | 0.180 |
Why?
|
Obstetric Labor Complications | 2 | 2019 | 93 | 0.180 |
Why?
|
Survival Analysis | 3 | 2021 | 1482 | 0.180 |
Why?
|
Erythrocyte Transfusion | 2 | 2019 | 127 | 0.180 |
Why?
|
Live Birth | 2 | 2020 | 54 | 0.180 |
Why?
|
Varicose Veins | 1 | 2021 | 28 | 0.180 |
Why?
|
Wound Closure Techniques | 1 | 2020 | 23 | 0.180 |
Why?
|
Simulation Training | 1 | 2022 | 139 | 0.170 |
Why?
|
Private Practice | 1 | 2020 | 22 | 0.170 |
Why?
|
Infant, Small for Gestational Age | 1 | 2020 | 57 | 0.170 |
Why?
|
Male | 16 | 2025 | 60962 | 0.170 |
Why?
|
Catheters, Indwelling | 1 | 2021 | 155 | 0.170 |
Why?
|
Intraoperative Complications | 1 | 2021 | 173 | 0.170 |
Why?
|
alpha-Fetoproteins | 1 | 2021 | 132 | 0.170 |
Why?
|
Ureteral Obstruction | 1 | 2021 | 105 | 0.170 |
Why?
|
Middle Cerebral Artery | 2 | 2022 | 107 | 0.170 |
Why?
|
Insufflation | 1 | 2020 | 20 | 0.170 |
Why?
|
Dose-Response Relationship, Drug | 2 | 2021 | 1685 | 0.170 |
Why?
|
Abdomen | 1 | 2020 | 127 | 0.170 |
Why?
|
Tricuspid Valve Insufficiency | 1 | 2020 | 63 | 0.160 |
Why?
|
Patient Care Team | 3 | 2019 | 545 | 0.160 |
Why?
|
Vasa Previa | 1 | 2019 | 9 | 0.160 |
Why?
|
Abortion, Induced | 1 | 2020 | 74 | 0.160 |
Why?
|
Remission, Spontaneous | 1 | 2019 | 69 | 0.160 |
Why?
|
Uterine Hemorrhage | 1 | 2019 | 43 | 0.160 |
Why?
|
Sensitivity and Specificity | 1 | 2024 | 2030 | 0.160 |
Why?
|
Health Resources | 1 | 2020 | 115 | 0.160 |
Why?
|
Hypocalcemia | 1 | 2019 | 36 | 0.160 |
Why?
|
Lymphatic Vessels | 1 | 2019 | 37 | 0.160 |
Why?
|
Lung Volume Measurements | 3 | 2025 | 75 | 0.160 |
Why?
|
Intraoperative Care | 1 | 2019 | 104 | 0.160 |
Why?
|
Preoperative Care | 1 | 2021 | 349 | 0.160 |
Why?
|
Fertilization in Vitro | 1 | 2020 | 146 | 0.160 |
Why?
|
Gynecology | 1 | 2020 | 123 | 0.160 |
Why?
|
Lymphatic Abnormalities | 1 | 2019 | 35 | 0.150 |
Why?
|
Hypertrophy | 1 | 2018 | 101 | 0.150 |
Why?
|
Movement Disorders | 1 | 2021 | 222 | 0.150 |
Why?
|
Lymphangioma | 1 | 2018 | 22 | 0.150 |
Why?
|
Nervous System Malformations | 1 | 2020 | 130 | 0.150 |
Why?
|
Streptococcal Infections | 1 | 2021 | 244 | 0.150 |
Why?
|
Developing Countries | 1 | 2020 | 268 | 0.150 |
Why?
|
Placentation | 1 | 2018 | 55 | 0.150 |
Why?
|
Lung Diseases | 1 | 2022 | 383 | 0.150 |
Why?
|
Neck | 1 | 2019 | 138 | 0.150 |
Why?
|
Blood Coagulation Disorders | 1 | 2019 | 101 | 0.150 |
Why?
|
Meningitis | 1 | 2018 | 98 | 0.150 |
Why?
|
Cerebrospinal Fluid Shunts | 1 | 2018 | 79 | 0.150 |
Why?
|
Anesthesia | 1 | 2020 | 211 | 0.150 |
Why?
|
Uterine Artery | 1 | 2018 | 29 | 0.150 |
Why?
|
Labor Onset | 1 | 2017 | 4 | 0.140 |
Why?
|
Gravidity | 1 | 2017 | 10 | 0.140 |
Why?
|
Bradycardia | 1 | 2018 | 59 | 0.140 |
Why?
|
Delayed Diagnosis | 1 | 2019 | 125 | 0.140 |
Why?
|
Imaging, Three-Dimensional | 1 | 2020 | 371 | 0.140 |
Why?
|
MEDLINE | 1 | 2017 | 20 | 0.140 |
Why?
|
Hypothermia | 1 | 2018 | 55 | 0.140 |
Why?
|
Fetal Development | 1 | 2019 | 131 | 0.140 |
Why?
|
Dystocia | 1 | 2017 | 23 | 0.140 |
Why?
|
Trial of Labor | 1 | 2017 | 21 | 0.140 |
Why?
|
Intensive Care Units, Neonatal | 2 | 2019 | 319 | 0.140 |
Why?
|
Obstetrics | 1 | 2020 | 237 | 0.140 |
Why?
|
Head and Neck Neoplasms | 2 | 2021 | 497 | 0.140 |
Why?
|
Cystoscopy | 1 | 2017 | 44 | 0.140 |
Why?
|
Reproductive Techniques, Assisted | 1 | 2017 | 70 | 0.140 |
Why?
|
Laryngoscopy | 1 | 2019 | 150 | 0.140 |
Why?
|
beta 2-Microglobulin | 1 | 2016 | 32 | 0.140 |
Why?
|
Osmolar Concentration | 1 | 2016 | 177 | 0.130 |
Why?
|
Ultrasonography, Interventional | 1 | 2018 | 193 | 0.130 |
Why?
|
Anastomosis, Surgical | 1 | 2017 | 168 | 0.130 |
Why?
|
Influenza Vaccines | 1 | 2021 | 477 | 0.130 |
Why?
|
Pain Management | 1 | 2018 | 181 | 0.130 |
Why?
|
Infertility, Female | 1 | 2017 | 145 | 0.130 |
Why?
|
Chlorides | 1 | 2016 | 106 | 0.130 |
Why?
|
Hypertension, Pulmonary | 1 | 2021 | 433 | 0.130 |
Why?
|
Anti-Arrhythmia Agents | 1 | 2018 | 219 | 0.130 |
Why?
|
Laparoscopy | 1 | 2021 | 489 | 0.130 |
Why?
|
Virus Diseases | 1 | 2019 | 279 | 0.130 |
Why?
|
Neuroimaging | 1 | 2019 | 340 | 0.130 |
Why?
|
Interdisciplinary Communication | 1 | 2017 | 133 | 0.130 |
Why?
|
Infant, Extremely Premature | 1 | 2016 | 84 | 0.130 |
Why?
|
Drainage | 1 | 2017 | 258 | 0.130 |
Why?
|
Intubation, Intratracheal | 1 | 2019 | 293 | 0.130 |
Why?
|
Child, Preschool | 5 | 2024 | 14040 | 0.130 |
Why?
|
Sodium | 1 | 2016 | 294 | 0.120 |
Why?
|
Referral and Consultation | 1 | 2019 | 539 | 0.120 |
Why?
|
Probability | 1 | 2016 | 323 | 0.120 |
Why?
|
Influenza, Human | 1 | 2021 | 657 | 0.120 |
Why?
|
Kidney Failure, Chronic | 1 | 2023 | 874 | 0.120 |
Why?
|
Prognosis | 5 | 2024 | 4549 | 0.120 |
Why?
|
Disease Management | 1 | 2018 | 519 | 0.120 |
Why?
|
Logistic Models | 4 | 2021 | 1802 | 0.110 |
Why?
|
Models, Theoretical | 1 | 2016 | 358 | 0.110 |
Why?
|
Physicians | 1 | 2020 | 579 | 0.110 |
Why?
|
Practice Guidelines as Topic | 1 | 2020 | 1254 | 0.110 |
Why?
|
Biomedical Research | 1 | 2019 | 518 | 0.100 |
Why?
|
Combined Modality Therapy | 1 | 2016 | 1245 | 0.100 |
Why?
|
Organ Size | 2 | 2025 | 432 | 0.100 |
Why?
|
Hospitals, Pediatric | 1 | 2016 | 775 | 0.100 |
Why?
|
Decision Making | 1 | 2017 | 654 | 0.090 |
Why?
|
Calcium | 1 | 2016 | 1095 | 0.090 |
Why?
|
Brain | 2 | 2024 | 3002 | 0.090 |
Why?
|
Twins | 2 | 2021 | 68 | 0.090 |
Why?
|
Middle East | 2 | 2021 | 34 | 0.090 |
Why?
|
Renal Insufficiency, Chronic | 1 | 2019 | 717 | 0.090 |
Why?
|
Cerebrospinal Fluid Leak | 2 | 2021 | 44 | 0.090 |
Why?
|
Statistics, Nonparametric | 2 | 2021 | 425 | 0.090 |
Why?
|
Uterus | 3 | 2019 | 571 | 0.090 |
Why?
|
Risk Assessment | 1 | 2019 | 3380 | 0.080 |
Why?
|
Adolescent | 7 | 2022 | 19298 | 0.080 |
Why?
|
Egypt | 2 | 2020 | 23 | 0.080 |
Why?
|
Postoperative Period | 2 | 2020 | 333 | 0.080 |
Why?
|
Cost-Benefit Analysis | 2 | 2021 | 511 | 0.080 |
Why?
|
Infant Mortality | 2 | 2019 | 173 | 0.070 |
Why?
|
Severity of Illness Index | 3 | 2020 | 2887 | 0.070 |
Why?
|
Cross-Sectional Studies | 3 | 2021 | 3424 | 0.070 |
Why?
|
Child | 6 | 2023 | 24434 | 0.070 |
Why?
|
Multivariate Analysis | 2 | 2020 | 1416 | 0.060 |
Why?
|
Rh Isoimmunization | 1 | 2024 | 28 | 0.060 |
Why?
|
Parvoviridae Infections | 1 | 2024 | 36 | 0.060 |
Why?
|
Pregnancy Trimesters | 1 | 2024 | 34 | 0.060 |
Why?
|
Reproducibility of Results | 2 | 2021 | 2873 | 0.060 |
Why?
|
Pregnancy Trimester, Third | 1 | 2024 | 117 | 0.060 |
Why?
|
Cervix Uteri | 1 | 2023 | 63 | 0.050 |
Why?
|
Microarray Analysis | 1 | 2023 | 230 | 0.050 |
Why?
|
Cytomegalovirus Infections | 1 | 2024 | 218 | 0.050 |
Why?
|
Multicenter Studies as Topic | 1 | 2023 | 273 | 0.050 |
Why?
|
Tertiary Care Centers | 1 | 2023 | 236 | 0.050 |
Why?
|
Maryland | 1 | 2021 | 29 | 0.050 |
Why?
|
Fibrin | 1 | 2022 | 66 | 0.050 |
Why?
|
Dilatation | 1 | 2022 | 67 | 0.050 |
Why?
|
Fetal Movement | 1 | 2021 | 14 | 0.050 |
Why?
|
Clubfoot | 1 | 2021 | 19 | 0.050 |
Why?
|
Waist Circumference | 1 | 2021 | 88 | 0.050 |
Why?
|
Umbilical Cord | 1 | 2021 | 56 | 0.050 |
Why?
|
Iran | 1 | 2021 | 59 | 0.050 |
Why?
|
Intention | 1 | 2021 | 92 | 0.050 |
Why?
|
Encephalocele | 1 | 2021 | 52 | 0.050 |
Why?
|
Umbilical Veins | 1 | 2021 | 71 | 0.050 |
Why?
|
Preoperative Period | 1 | 2020 | 87 | 0.040 |
Why?
|
Respiratory Distress Syndrome, Newborn | 1 | 2021 | 79 | 0.040 |
Why?
|
Middle Aged | 4 | 2021 | 26451 | 0.040 |
Why?
|
United States | 3 | 2021 | 10765 | 0.040 |
Why?
|
Streptococcus agalactiae | 1 | 2021 | 105 | 0.040 |
Why?
|
Uterine Contraction | 1 | 2019 | 28 | 0.040 |
Why?
|
Antibiotic Prophylaxis | 1 | 2021 | 119 | 0.040 |
Why?
|
Decision Support Techniques | 1 | 2022 | 287 | 0.040 |
Why?
|
Time-to-Treatment | 1 | 2021 | 187 | 0.040 |
Why?
|
Resuscitation | 1 | 2022 | 246 | 0.040 |
Why?
|
Choroid Plexus | 1 | 2019 | 24 | 0.040 |
Why?
|
Platelet Transfusion | 1 | 2019 | 53 | 0.040 |
Why?
|
Risk | 1 | 2021 | 749 | 0.040 |
Why?
|
Infant Care | 1 | 2019 | 46 | 0.040 |
Why?
|
Maternal-Child Health Services | 1 | 2019 | 13 | 0.040 |
Why?
|
Ventriculostomy | 1 | 2019 | 36 | 0.040 |
Why?
|
Disseminated Intravascular Coagulation | 1 | 2019 | 67 | 0.040 |
Why?
|
Prenatal Exposure Delayed Effects | 1 | 2021 | 229 | 0.040 |
Why?
|
Perioperative Care | 1 | 2021 | 196 | 0.040 |
Why?
|
Postnatal Care | 1 | 2019 | 51 | 0.040 |
Why?
|
Infectious Disease Transmission, Vertical | 1 | 2021 | 240 | 0.040 |
Why?
|
Workflow | 1 | 2019 | 117 | 0.040 |
Why?
|
Plasma | 1 | 2019 | 96 | 0.040 |
Why?
|
Parturition | 1 | 2019 | 63 | 0.040 |
Why?
|
Academic Medical Centers | 1 | 2020 | 305 | 0.040 |
Why?
|
Regression Analysis | 1 | 2020 | 774 | 0.040 |
Why?
|
Cold Temperature | 1 | 2018 | 78 | 0.040 |
Why?
|
Genetic Testing | 1 | 2024 | 1004 | 0.040 |
Why?
|
Placenta, Retained | 1 | 2017 | 12 | 0.040 |
Why?
|
Patient Admission | 1 | 2019 | 186 | 0.040 |
Why?
|
Heart Rate, Fetal | 1 | 2018 | 61 | 0.040 |
Why?
|
Term Birth | 1 | 2017 | 32 | 0.040 |
Why?
|
Patient Positioning | 1 | 2018 | 53 | 0.040 |
Why?
|
Oxytocics | 1 | 2017 | 28 | 0.040 |
Why?
|
Longitudinal Studies | 1 | 2021 | 1320 | 0.040 |
Why?
|
Hepatitis B | 1 | 2019 | 160 | 0.040 |
Why?
|
Mass Screening | 1 | 2023 | 783 | 0.040 |
Why?
|
Maternal Age | 1 | 2017 | 132 | 0.030 |
Why?
|
World Health Organization | 1 | 2017 | 100 | 0.030 |
Why?
|
Program Evaluation | 1 | 2019 | 447 | 0.030 |
Why?
|
Clinical Decision-Making | 1 | 2019 | 267 | 0.030 |
Why?
|
Survival Rate | 1 | 2022 | 2019 | 0.030 |
Why?
|
Oxytocin | 1 | 2017 | 68 | 0.030 |
Why?
|
Isotonic Solutions | 1 | 2017 | 35 | 0.030 |
Why?
|
Blood Transfusion | 1 | 2019 | 307 | 0.030 |
Why?
|
Endoscopy | 1 | 2019 | 284 | 0.030 |
Why?
|
Analgesics, Opioid | 1 | 2021 | 409 | 0.030 |
Why?
|
Anxiety | 1 | 2023 | 966 | 0.030 |
Why?
|
Maternal Exposure | 1 | 2018 | 148 | 0.030 |
Why?
|
Emergencies | 1 | 2017 | 173 | 0.030 |
Why?
|
Vaccination | 1 | 2021 | 953 | 0.030 |
Why?
|
Renal Dialysis | 1 | 2023 | 849 | 0.030 |
Why?
|
Analysis of Variance | 1 | 2018 | 1017 | 0.030 |
Why?
|
Follow-Up Studies | 1 | 2024 | 5103 | 0.030 |
Why?
|
Length of Stay | 1 | 2021 | 1307 | 0.030 |
Why?
|
Stents | 1 | 2022 | 885 | 0.030 |
Why?
|
Counseling | 1 | 2017 | 216 | 0.030 |
Why?
|
Hepatitis C | 1 | 2019 | 364 | 0.030 |
Why?
|
Mothers | 1 | 2018 | 352 | 0.030 |
Why?
|
Algorithms | 1 | 2022 | 1612 | 0.030 |
Why?
|
Inflammation | 1 | 2022 | 1414 | 0.030 |
Why?
|
Attitude of Health Personnel | 1 | 2020 | 672 | 0.030 |
Why?
|
Depression | 1 | 2023 | 1243 | 0.030 |
Why?
|
Health Knowledge, Attitudes, Practice | 1 | 2020 | 847 | 0.030 |
Why?
|
Quality of Health Care | 1 | 2017 | 388 | 0.030 |
Why?
|
Double-Blind Method | 1 | 2017 | 1617 | 0.030 |
Why?
|
Disease Progression | 1 | 2019 | 2039 | 0.030 |
Why?
|
Anti-Bacterial Agents | 1 | 2021 | 2416 | 0.020 |
Why?
|
HIV Infections | 1 | 2019 | 1890 | 0.020 |
Why?
|